Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide plus Tiotropium in COPD
NCT00325169Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluticasone propionate, salmeterol, tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Dec 2005; status: completed.
02
Drugs
fluticasone propionatesalmeteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00325169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325169.